Incidence trends of cervical adenocarcinoma in Israeli Jewish women. A population-based study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 3, 2009, Pages 280-285

  Menczer, Joseph ^a   Kogan, Liron ^a   Liphshiz, Irena ^b   Barchana, Micha ^b,c  

^a WOLFSON MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

Author keywords

Cervical adenocarcinoma; Cervical squamous carcinoma; Incidence trends; Relative frequency

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER REGISTRY; CERVICAL ADENOCARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISRAEL; MAJOR CLINICAL STUDY; NORTH AFRICA; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; ISRAEL; JEWS; MIDDLE AGED; REGISTRIES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 60849085713     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340902730391     Document Type: Article

References (31)

1. Moore DH. Cervical cancer. Obstet Gynecol. 2006;107:1152-61.
2. Castellsague X, Diaz M, de Sanjose S, Muñoz N, Herrero R, Franceschi S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006;98:303-15.
3. Andersson S, Rylander E, Larson B, Sigurdardottir S, Backlund I, Sällström J, et al. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing. Oncol Rep. 2003;10:175-9.
4. Leminen A, Paavonen J, Forss M, Wahlström T, Vesterinen E. Adenocarcinoma of the uterine cervix. Cancer. 1990;65:53-9.
5. Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol. 1990;39:40-6.
6. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population-based study. Gynecol Oncol. 2000;78:97-105.
7. Liu S, Semenciw R, Probert A, Mao Y. Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer. 2001;11:24-31.
8. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer. 2004;100:1035-44.
9. Bray F, Carstensen B, Møller H, Zappa M, Zakelj MP, Lawrence G, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev. 2005;14:2191-9.
10. Herzog TJ, Monk BJ. Reducing the burden of glandular carcinomas of the uterine cervix. Am J Obstet Gynecol. 2007;197:566-71.
11. Nieminen P, Kallio M, Hakama M. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol. 1995;85:1017-21.
12. Howlett RI, Marrett LD, Innes MK, Rosen BP, McLachlin CM. Decreasing incidence of cervical adenocarcinoma in Ontario: is this related to improved endocervical Pap test sampling? Int J Cancer. 2007;120:362-7.
13. Parkin DM, Bray F, Ferlay J, Teppo L, Thomas DB, editors. Cancer in five continents, vol. VIII. Lyon: IARC Scientific Publications No. 155, 2002.
14. Steinitz R. Five year morbidity from neoplasms in Israel's population groups (1960-1964). Jerusalem: Ministry of Health; 1967.
15. Steinitz R, Costin C. Cancer in Israel, facts and figures 1960-1966. Jerusalem: Ministry of Health and Israel Cancer Association; 1971.
16. Barchana M, Andreev H, Alon R. Israel Cancer Registry. Cancer in Israel 1994. Jerusalem: Ministry of Health; 1997.
17. Fishler Y Chitrit A Barchana M Modan B Examination of Israel national cancer data accumulation completeness for 1991. Tel Hashomer, Israel: The National Center for Disease Control, Publication No. 230, 2003 (in Hebrew).
18. The Central Bureau of Statistics (Israel). www.cbs.gov.il (accessed 2006).
19. Vizcaino AP, Moreno V, Bosch FX, Muñoz N, Barros-Dios XM, Parkin DM. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer. 1998;75:536-45.
20. Hemminki K, Li X, Vaittinen P. Time trends in the incidence of cervical cancer and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996. Eur J Obstet Gynecol Reprod Biol. 2002;101:64-9.
21. Kyndi M, Frederiksen K, Krüger Kjaer S. Cervical cancer incidence in Denmark over six decades 1943. Acta Obstet Gynecol Scand. 2006;85:106-11.
22. Zheng T, Holford TR, Ma Z, Chen Y, Liu W, Ward BA, et al. The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. Int J Epidemiol. 1996;25:252-8.
23. Andersson S, Larson B, Hjerpe A, Silfverswärd C, Sällström J, Wilander E, et al. Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection. Acta Obstet Gynecol Scand. 2003;82:960-5.
24. Zappa M, Visioli CB, Ciatto S, Iossa A, Paci E, Sasieni P. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer. 2004;90:1784-6.
25. Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet. 2001;357:1490-3.
26. Kedar-Barnes I, Rozen P. The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility. Fam Cancer. 2004;3:193-9.
27. Rozen P, Liphshitz I, Barchana M. Changing sites of colorectal cancer in the Israeli Jewish ethnic populations and its clinical implications. Eur J Cancer Prev. 2007;16:1-9.
28. Modan B, Sharon Z, Shani M, Sheba Ch. A comparison of some epidemiological aspects of cervical and endometrial carcinoma. Path Microbiol. 1970;35:192-7.
29. Sharon Z, Shani M, Modan B. Clinicoepidemiologic study of uterine cancer. Comparative aspects of the endometrial and cervical sites. Obstet Gynecol. 1977;50:536-40.
30. Menczer J, Modan B, Oelsner G, Sharon Z, Steinitz R, Sampson S. Adenocarcinoma of the uterine cervix in Jewish women. A distinct epidemiologic entity. Cancer. 1978;41:2464-8.
31. Arbel-Alon S, Menczer J, Feldman N, Glezerman M, Yeremin L, Friedman E. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women. Int J Gynecol Cancer. 2002;12:741-4.